Minsig Choi

Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial

Josep M. Llovet, Masatoshi Kudo, Philippe Merle et al. · The Lancet Oncology · 2023 · 364 citations

Oncology, Hepatology, Medicine +10

Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study

Bruno Sangro, Masatoshi Kudo, Joseph P. Erinjeri et al. · The Lancet · 2025 · 151 citations · Full text

Hepatology, Transarterial Chemoembolisation, Medicine +8

A randomized, phase II trial of cetuximab with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic head and neck squamous cell cancer

Antonio Jimeno, Keisuke Shirai, Minsig Choi et al. · Annals of Oncology · 2014 · 98 citations · Full text

Ii Trial, Medicine, Pharmacology +9

Using 18F-Fluorodeoxyglucose Positron Emission Tomography to Monitor Clinical Outcomes in Patients Treated With Neoadjuvant Chemo-Radiotherapy for Locally Advanced Pancreatic Cancer

Minsig Choi, Lance K. Heilbrun, Raghu Venkatramanamoorthy et al. · American Journal of Clinical Oncology · 2010 · 91 citations · Full text

Direct therapeutic targeting of immune checkpoint PD-1 in pancreatic cancer

Mei Gao, Miranda Lin, Richard A. Moffitt et al. · British Journal of Cancer · 2018 · 54 citations · Full text